Targeting aging cells improves survival
- 16 July 2021
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 373 (6552) , 281-282
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic ManagementJournal of Cardiovascular Pharmacology and Therapeutics, 2020
- A proteomic atlas of senescence-associated secretomes for aging biomarker developmentPLOS Biology, 2020
- Cellular senescence: at the nexus between ageing and diabetesDiabetologia, 2019
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot studyEBioMedicine, 2019
- mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related DiseasesInternational Journal of Molecular Sciences, 2018
- Senolytics improve physical function and increase lifespan in old ageNature Medicine, 2018
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespanNature, 2016
- Cellular senescence in aging and age-related disease: from mechanisms to therapyNature Medicine, 2015
- The Hallmarks of AgingCell, 2013
- Inflamm‐aging: An Evolutionary Perspective on ImmunosenescenceAnnals of the New York Academy of Sciences, 2000